COVID-19 related urgent care visit, emergency room assessment, hospitalization or death by Day 28 (Primary efficacy endpoint);SARS-CoV-2 RNA negativity (Primary virological endpoint);Treatment-emergent and treatment-related serious adverse events (Primary safety endpoint)

COVID-19 related urgent care visit, emergency room assessment, hospitalization or death by Day 28 (Primary efficacy endpoint);SARS-CoV-2 RNA negativity (Primary virological endpoint);Treatment-emergent and treatment-related serious adverse events (Primary safety endpoint)